{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:39:48Z","timestamp":1791614388945,"version":"4.3.4"},"reference-count":25,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Ethics"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1136\/medethics-2013-101887","type":"journal-article","created":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T08:19:46Z","timestamp":1401351586000},"page":"322-326","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":101,"title":["Personal utility in genomic testing: is there such a thing?"],"prefix":"10.1136","volume":"41","author":[{"given":"Eline M","family":"Bunnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Cecile J W","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maartje H N","family":"Schermer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,5,28]]},"reference":[{"key":"key-10.1136\/medethics-2013-101887-1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJMoa1011893","article-title":"Effect of direct-to-consumer genomewide profiling to assess disease risk","volume":"364","author":"Bloss","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.1136\/medethics-2013-101887-2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/GIM.0b013e3181b13a6c","article-title":"The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop","volume":"11","author":"Khoury","year":"2009","journal-title":"Genet Med"},{"key":"key-10.1136\/medethics-2013-101887-3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/GIM.0b013e3181a2743e","article-title":"Evaluating the utility of personal genomic information","volume":"11","author":"Foster","year":"2009","journal-title":"Genet Med"},{"issue":"(1)","key":"key-10.1136\/medethics-2013-101887-4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/nbt.2469","article-title":"The challenge of personal genomics in Germany","volume":"31","author":"Vayena","year":"2013","journal-title":"Nat Biotechnol"},{"key":"key-10.1136\/medethics-2013-101887-5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tig.2009.12.007","article-title":"Personal genome research : what should the participant be told?","volume":"26","author":"McGuire","year":"2010","journal-title":"Trends Genet"},{"issue":"(1)","key":"key-10.1136\/medethics-2013-101887-6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cge.12167","article-title":"\u2018Information is information\u2019: a public perspective on incidental findings in clinical and research genome-based testing","volume":"84","author":"Daack-Hirsch","year":"2013","journal-title":"Clin Genet"},{"key":"key-10.1136\/medethics-2013-101887-7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-90-481-9485-8_8","article-title":"Evaluation of the validity and utility of genetic testing for rare diseases","volume":"686","author":"Grosse","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"key-10.1136\/medethics-2013-101887-8","article-title":"Variations in predicted risks in personal genome testing for common complex diseases","author":"Kalf","journal-title":"Genet Med"},{"issue":"(12)","key":"key-10.1136\/medethics-2013-101887-9","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1373\/clinchem.2012.182576","article-title":"Beyond diagnostic accuracy: the clinical utility of diagnostic tests","volume":"58","author":"Bossuyt","year":"2012","journal-title":"Clin Chem"},{"key":"key-10.1136\/medethics-2013-101887-10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pec.2006.03.002","article-title":"Genetic susceptibility testing for Alzheimer disease: motivation to obtain information and control as precursors to coping with increased risk","volume":"64","author":"Gooding","year":"2006","journal-title":"Patient Educ Couns"},{"key":"key-10.1136\/medethics-2013-101887-11","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/gtmb.2011.0028","article-title":"Willingness to pay for genetic testing for Alzheimer's disease: a measure of personal utility","volume":"15","author":"Kopits","year":"2011","journal-title":"Genet Test Mol Biomarkers"},{"key":"key-10.1136\/medethics-2013-101887-12","volume-title":"Principles and practice of screening for disease","author":"Wilson","year":"1968"},{"key":"key-10.1136\/medethics-2013-101887-13","volume-title":"Genetic screening: ethical issues","author":"Nuffield Council on Bioethics","year":"1993"},{"key":"key-10.1136\/medethics-2013-101887-14","volume-title":"Witness seminar: debatteren over Genetische Screeningscriteria","author":"Van El","year":"2010"},{"key":"key-10.1136\/medethics-2013-101887-15","unstructured":"Pinker S . My genome, my self. New York Times Magazine, 7 Jan 2009."},{"issue":"(6)","key":"key-10.1136\/medethics-2013-101887-16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000343792","article-title":"Experiences of early users of direct-to-consumer genomics in Switzerland: an exploratory study","volume":"15","author":"Vayena","year":"2012","journal-title":"Public Health Genomics"},{"issue":"(6)","key":"key-10.1136\/medethics-2013-101887-17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/jme.27.6.398","article-title":"Let the consumer decide? The regulation of commercial genetic testing","volume":"27","author":"Levitt","year":"2001","journal-title":"J Med Ethics"},{"issue":"(1)","key":"key-10.1136\/medethics-2013-101887-18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/gte.2007.0024","article-title":"Evaluating online direct-to-consumer marketing of genetic tests: informed choices or buyers beware?","volume":"12","author":"Geransar","year":"2008","journal-title":"Genet Test"},{"issue":"(37)","key":"key-10.1136\/medethics-2013-101887-19","first-page":"37cm19","article-title":"Multidimensional results reporting to participants in genomic studies: getting it right","volume":"2","author":"Kohane","year":"2010","journal-title":"Sci Transl Med"},{"key":"key-10.1136\/medethics-2013-101887-20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/01.gim.0000227935.26763.c6","article-title":"What is the clinical utility of genetic testing?","volume":"8","author":"Grosse","year":"2006","journal-title":"Genet Med"},{"issue":"(3)","key":"key-10.1136\/medethics-2013-101887-21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/ejhg.2012.179","article-title":"Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeq study","volume":"21","author":"Facio","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"key-10.1136\/medethics-2013-101887-22","volume-title":"The value of genetic and genomic technologies: workshop summary","author":"Roundtable on Translating Genomic-Based Research for Health","year":"2010"},{"issue":"(14)","key":"key-10.1136\/medethics-2013-101887-23","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.2013.1438","article-title":"The indispensable role of professional judgment in genomic medicine","volume":"309","author":"McGuire","year":"2013","journal-title":"JAMA"},{"issue":"(1)","key":"key-10.1136\/medethics-2013-101887-24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.ejhg.5201724","article-title":"Association analysis of the ACTN3 R577X polymorphism and complex quantitative body composition and performance phenotypes in adolescent Greeks","volume":"15","author":"Moran","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"key-10.1136\/medethics-2013-101887-25","article-title":"Pathway genomics to launch Next-Generation Sequencing (NGS) comprehensive cancer panel including BRCA1 and BRCA2"}],"container-title":["Journal of Medical Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/medethics-2013-101887","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T19:30:26Z","timestamp":1601062226000},"score":1,"resource":{"primary":{"URL":"https:\/\/jme.bmj.com\/lookup\/doi\/10.1136\/medethics-2013-101887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,28]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,3,23]]},"published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.1136\/medethics-2013-101887"],"URL":"https:\/\/doi.org\/10.1136\/medethics-2013-101887","relation":{},"ISSN":["0306-6800","1473-4257"],"issn-type":[{"value":"0306-6800","type":"print"},{"value":"1473-4257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,28]]}}}